Method for diagnosing efficacy of xenotypic antibody therapy

Details for Australian Patent Application No. 2006203074 (hide)

Owner AltaRex Medical Corp.

Inventors Noujaim, Antoine A

Agent Shelston IP

Pub. Number AU-A-2006203074

Parent 2001240982

Filing date 18 July 2006

Wipo publication date 10 August 2006

International Classifications

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

G01N 33/569 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for micro-organisms, e.g. protozoa, bacteria, viruses

G01N 33/574 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for cancer

Event Publications

3 August 2006 Complete Application Filed

10 August 2006 Application Open to Public Inspection

  Published as AU-A-2006203074

4 September 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006203075-Automatic systems and methods for positioning marine seismic equipment

2006203073-Improved Battery Receptacle